DSpace logo

Browsing by Author Murugesan, Sankaranarayanan

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 49 to 59 of 59 < previous 
Issue DateTitleAuthor(s)
2020Screening Marine Natural Products for New Drug Leads against Trypanosomatids and MalariaMurugesan, Sankaranarayanan
2021-01Search for new therapeutics against HIV-1 via dual inhibition of RNase H and integrase: current status and future challengesMurugesan, Sankaranarayanan
2020Seeking potent anti-tubercular agents: design and synthesis of substituted-N-(6-(4-(pyrazine-2-carbonyl)piperazine/homopiperazine-1-yl)pyridin-3-yl)benzamide derivatives as anti-tubercular agentsMurugesan, Sankaranarayanan
2020Sequential multicomponent catalytic synthesis of pyrrole-3-carboxaldehydes: Evaluation for antibacterial and antifungal activities along with docking studiesMurugesan, Sankaranarayanan
2017-02Synthesis and in-vitro anti-leishmanial activity of (4-arylpiperazin-1-yl)(1-(thiophen-2-yl)-9H-pyrido[3,4-b]indol-3-yl)methanone derivativesJha, Prabhat N.; Murugesan, Sankaranarayanan
2020-10Synthesis, biological evaluation, molecular docking, molecular dynamics and DFT studies of quinoline-fluoroproline amide hybridsMurugesan, Sankaranarayanan
2015-12Synthesis, evaluation and molecular docking studies of amino acid derived N-glycoconjugates as antibacterial agentsJha, Prabhat N.; Sah, Ajay Kumar; Murugesan, Sankaranarayanan
2022Systematic Down-Selection of Repurposed Drug Candidates for COVID-19Murugesan, Sankaranarayanan
2020-12Targeting a conserved pocket (n-octyl-β-D–glucoside) on the dengue virus envelope protein by small bioactive molecule inhibitorsMurugesan, Sankaranarayanan
2023Tetrahydroisoquinoline based 5-nitro-2-furoic acid derivatives: a promising new approach for anti-tubercular agentsMurugesan, Sankaranarayanan
2022-10Use of Human Lung Tissue Models for Screening of Drugs against SARS-CoV-2 InfectionMurugesan, Sankaranarayanan